109 related articles for article (PubMed ID: 21084739)
21. A new peptide-based urethane polymer: synthesis, biodegradation, and potential to support cell growth in vitro.
Zhang JY; Beckman EJ; Piesco NP; Agarwal S
Biomaterials; 2000 Jun; 21(12):1247-58. PubMed ID: 10811306
[TBL] [Abstract][Full Text] [Related]
22. Removal of lead ions in aqueous solution by hydroxyapatite/polyurethane composite foams.
Jang SH; Min BG; Jeong YG; Lyoo WS; Lee SC
J Hazard Mater; 2008 Apr; 152(3):1285-92. PubMed ID: 17850963
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 1-octadecanol-modified water-swelling polyurethane hydrogels as vaginal drug-delivery vehicle.
Yuan D; Ju C; Ding S; Jing X; Zhang C
J Biomater Sci Polym Ed; 2010; 21(4):493-505. PubMed ID: 20233505
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone.
Zhang Y; Zhuo RX
Biomaterials; 2005 Nov; 26(33):6736-42. PubMed ID: 15935469
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of in vitro calcium phosphate precipitation in presence of polyurethane via surface modification and drug delivery.
Chandy T; Kumar BA; Sharma CP
J Appl Biomater; 1994; 5(3):245-54. PubMed ID: 10147451
[TBL] [Abstract][Full Text] [Related]
26. Atmospheric pressure liquefaction of dried distillers grains (DDG) and making polyurethane foams from liquefied DDG.
Yu F; Le Z; Chen P; Liu Y; Lin X; Ruan R
Appl Biochem Biotechnol; 2008 Mar; 148(1-3):235-43. PubMed ID: 18418755
[TBL] [Abstract][Full Text] [Related]
27. Long-term in vivo biostability of poly(dimethylsiloxane)/poly(hexamethylene oxide) mixed macrodiol-based polyurethane elastomers.
Simmons A; Hyvarinen J; Odell RA; Martin DJ; Gunatillake PA; Noble KR; Poole-Warren LA
Biomaterials; 2004 Sep; 25(20):4887-900. PubMed ID: 15109849
[TBL] [Abstract][Full Text] [Related]
28. Development and characterisation of novel cross-linked bio-elastomeric materials.
Srokowski EM; Woodhouse KA
J Biomater Sci Polym Ed; 2008; 19(6):785-99. PubMed ID: 18534097
[TBL] [Abstract][Full Text] [Related]
29. Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes.
Guo Q; Knight PT; Mather PT
J Control Release; 2009 Aug; 137(3):224-33. PubMed ID: 19376173
[TBL] [Abstract][Full Text] [Related]
30. [Biocompatible antibacterial polymer coatings with ciprofloxacin extended release].
Iarmolenko MA; Tapal'skiĭ DB; Rogachev AV; Rogachev AA; Kozlova AI
Antibiot Khimioter; 2007; 52(11-12):3-7. PubMed ID: 19275049
[TBL] [Abstract][Full Text] [Related]
31. Characterization of biodegradable polyurethane microfibers for tissue engineering.
Rockwood DN; Woodhouse KA; Fromstein JD; Chase DB; Rabolt JF
J Biomater Sci Polym Ed; 2007; 18(6):743-58. PubMed ID: 17623555
[TBL] [Abstract][Full Text] [Related]
32. Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding.
Vaz CM; van Doeveren PF; Dias GR; Reis RL; Cunha AM
Macromol Biosci; 2004 Aug; 4(8):795-801. PubMed ID: 15468273
[TBL] [Abstract][Full Text] [Related]
33. The release of bovine serum albumin from polyurethane based hydrophilic and hydrophobic disks and microbiological interactions.
Pulat M; Ekmekci A; Aslim B
Biomed Mater Eng; 2006; 16(2):147-56. PubMed ID: 16477123
[TBL] [Abstract][Full Text] [Related]
34. Fatty acid-derived diisocyanate and biobased polyurethane produced from vegetable oil: synthesis, polymerization, and characterization.
Hojabri L; Kong X; Narine SS
Biomacromolecules; 2009 Apr; 10(4):884-91. PubMed ID: 19281152
[TBL] [Abstract][Full Text] [Related]
35. The hydrolytic stability of Mitrathane (a polyurethane urea)--an x-ray photoelectron spectroscopy study.
Paynter RW; Askill IN; Glick SH; Guidoin R
J Biomed Mater Res; 1988 Aug; 22(8):687-98. PubMed ID: 3215906
[TBL] [Abstract][Full Text] [Related]
36. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
37. In-vitro and in-vivo antibacterial activity evaluation of a polyurethane matrix.
Lee SH; Kim SR; Kim JS; Bae HR; Lee CH; Kim DD
J Pharm Pharmacol; 2003 Apr; 55(4):559-66. PubMed ID: 12803779
[TBL] [Abstract][Full Text] [Related]
38. Examination of hard segment and soft segment phase separation in polyurethane medical materials by electron microscopy techniques.
Taylor JE; Laity PR; Wong SS; Norris K; Khunkamchoo P; Cable M; Andrews G; Johnson AF; Cameron RE
Microsc Microanal; 2006 Apr; 12(2):151-5. PubMed ID: 17481351
[TBL] [Abstract][Full Text] [Related]
39. Biodegradation evaluation of polyether and polyester-urethanes with oxidative and hydrolytic enzymes.
Santerre JP; Labow RS; Duguay DG; Erfle D; Adams GA
J Biomed Mater Res; 1994 Oct; 28(10):1187-99. PubMed ID: 7829548
[TBL] [Abstract][Full Text] [Related]
40. Hydroxyapatite particles as a controlled release carrier of protein.
Matsumoto T; Okazaki M; Inoue M; Yamaguchi S; Kusunose T; Toyonaga T; Hamada Y; Takahashi J
Biomaterials; 2004 Aug; 25(17):3807-12. PubMed ID: 15020156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
